86
Views
4
CrossRef citations to date
0
Altmetric
Guidelines

Guidelines for aetiological investigation into severe to profound bilateral permanent childhood hearing impairment

Produced by the British Association of Audiovestibular Physicians (BAAP) (Appendix 5) 2015

References

  • MacArdle B, Bitner-Glindzicz M. Investigation of the child with permanent hearing impairment. Arch Dis Child Educ Pract Ed. 2010;95:14–23. [Review]
  • British Association of Audiovestibular Physicians manual for producing guidelines, Clinical Standards Subcommittee BAAP, 2013. [Guideline]
  • Woolf SH, Grol R, Hutchinson A, et al. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318:527–530.
  • Quality Standards in the NHS Newborn Hearing Screening Programme September 2010. [Quality Standard Document]; [cited 4 Apr 2014]. Available from: http://hearing.screening.nhs.uk/standardsandprotocols#fileid10752.
  • Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323:334–336.
  • General Medical Council. Good Medical Practice London GMC. 2013; [cited 29 Apr 2014]. Available from: http://www.gmc-uk.org/guidance/good_medical_practice.asp.
  • Hampton JR, Harrison MJG, Mitchell JRA, et al. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. BMJ. 1975;2:486–489. [level 3]
  • Paley L, Zornitski T, Cohen J, et al. Utility of clinical examination in the diagnosis of emergency department patients admitted to the department of medicine of an academic hospital. Arch Intern Med. 2011;171:1393–1400. [level 3]
  • Yield of investigations from the BAAP National Audit, 2013. Unpublished data, BAAP. [level 3]
  • Stephens D. Audiometric investigation of first- degree relatives. In: Martini A, Mazzoli M, Stephens, D, Read A. editors. Definitions, protocols & guidelines in genetic hearing impairment. London: Whurr Publishers; 2001. p. 32–33.
  • Stephens D, Meredith R, Sirimanna T, et al. Application of the Audioscan in the detection of carriers of genetic hearing loss. Audiology. 1995;34:91–97. [Level 2-]
  • Rao S, Peacock K, Hawker R. Prevalance of QTc abnormalities in a population of children with Sensorineural hearing loss. Heart Lung Circ. 2012;21:S143–S316. [level 3]
  • Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88:782–784. [Review]
  • Schwartz PJ, Spazzolini C, Crotti L, et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation. 2006;113:783–790. [level 3]
  • Siem G, Früh A, Leren TP, et al. Jervell and Lange-Nielsen syndrome in Norwegian children; aspects around cochlear implantation, hearing and balance. Ear Hear. 2008;29:261–269. [level 3]
  • Nikolopoulos TP, Lioumi D, Stamataki S, et al. Evidence-based overview of ophthalmic disorders in deaf children: a literature update. Otol Neurotol. 2006;27:S1–S24. [level 2++]
  • Abah ER, Oladigbolu KK, Samaila E, et al. Ophthalmologic abnormalities among deaf students in Kaduna, Northern Nigeria. Ann Afr Med. 2011;10:29–33. [level 3]
  • Johnstone DR, Curry JM, Newborough B, et al. Ophthalmologic disorders in children with syndromic and nonsyndromic hearing loss. Arch Otolaryngol Head Neck Surg. 2010;136:277–280. [level 2-]
  • Sharma A, Ruscetta MN, Chi DH. Ophthalmologic findings in children with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2009;135:119–123. [level 2+]
  • Quality Standards in Vision Care for Deaf Children and Young People. Guidelines for professionals. [NDCS and SENSE 2009]. [Quality Standards Document]
  • Siatkowski RM, Flynn JT, Hodges AV, et al. Ophthalmologic abnormalities in the pediatric cochlear implant population. Am J Ophthalmol. 1994;118:70–76. [level 3]
  • Armitage IM, Burke JP, Buffin JT. Visual impairment in severe and profound sensorineural deafness. Arch Dis Child. 1995;75:53–56. [level 2-]
  • Young NM, Mets MB, Hain TC. Early diagnosis of Usher syndrome in infants and children. Am J Otol. 1996;17:30–34. [level 2-]
  • Savige J, Gregory M, Gross O, et al. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013;24:364–375. [level 3]
  • Kashtan CE, Ding J, Gregory M. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol. 2013;28:5–11. [Guideline]
  • Raju P, Cimbaluk D, Korbet SM. The variable course of women with X-linked Alport Syndrome. Clin Kidney J. 2013;6:630–634. [level 3]
  • Alves FR, de A Quintanilha Ribeiro F. Revision about hearing loss in the Alport’s syndrome, analyzing the clinical, genetic and bio-molecular aspects. Braz J Otorhinolaryngol. 2005;71:813–819. [level 3]
  • Boppana SB, Ross SA, Shimamura M, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364:2111–2118. [level 2+]
  • Boppana Sb, Ross SA, Novak Z, et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 2010;303:1375–1382. [level 2+]
  • Barbi M, Binda S, Primache V, et al. Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol. 2000;17:159–165. [level 2+]
  • Williams EJ, Kadambari S, Berrington JE, et al. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss. Arch Dis Child Fetal Neonatal Ed. 2014;99:F230–F236.
  • de Vries JJ, van der Eijk AA, Wolthers KC, et al. Real time PCR versus viral culture on urine as a gold standard in the diagnosis of congenital cytomegalovirus infection. J Clin Virol. 2012;53:167–170.
  • Atkinson C, Walter S, Sharland M, et al. Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J Med Virol. 2009;81:1394–1398.
  • Tagawa M, Tanaka H, Moriuchi M, et al. Retrospective diagnosis of congenital cytomegalovirus infection at a school for deaf by using preserved dried umbilical cord. J Paediatr. 2009;155:749–751. [level 2-]
  • Enders G, Daiminger A, Bäder U, et al. The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. J Clin Virol. 2013;56:102–107. [Level 2+]
  • Clinical Virology Network Guidelines. Unpublished data. Available from: http://www.clinicalvirology.org/guidelines/.
  • Lucassen A, Hall A. Consent and confidentiality in clinical genetic practice: guidance on genetic testing and sharing genetic information. A report of the Joint Committee on Medical Genetics. Clin Med. 2012;12:5–6.
  • Kenna MA, Feldman HA, Neault MW, et al. Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. Arch Otolaryngol Head Neck Surg. 2010;136:81–87. [level 2+]
  • Ballana E, Ventayol M, Rabionet R, et al. Connexins and deafness Homepage; [cited 29 July 2016]. Available from: http://www.crg.es/deafness
  • Denoyelle F, Weil D, Maw MA, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet. 1997;6:2173–2177. [level 3]
  • Kessell D, Dunlop J, Stevens HP, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature. 1997;387:80–83.
  • Shearer A, DeLuca A, Hildebrand M, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA. 2010;107:21104–21109. [level 3]
  • Hoefsloot LH, Roux AF, Bitner-Glindzicz M. EMQN Best Practice guidelines for diagnostic testing of mutations causing non-syndromic hearing impairment at the DFNB1 locus. Eur J Hum Genet. 2013;21:1325–1329. [Guideline]
  • Bamiou D, Phelps P, Sirimanna T. Temporal bone computed tomography findings in bilateral sensorineural hearing loss. Arch Dis Child. 2000;82:257–260. [level 3]
  • Chilosi A, Comparini A, Scusa M, et al. Neurodevelopmental disorders in children with severe to profound sensorineural hearing loss: a clinical study. Dev Med Child Neurol. 2010;52:856–862. [level 3]
  • Roche JP, Huang BY, Castillo M, et al. Imaging characteristics of children with auditory neuropathy spectrum disorder. Otol Neurotol. 2010;31:780–788. [level 3]
  • Lin JW, Chowdhury N, Mody A, et al. Comprehensive diagnostic battery for evaluating sensorineural hearing loss in children. Otol Neurotol. 2011;32:259–264. [level 3]
  • Wiley S, Arjmand E, Jareenmeinzen-Derr, et al. Findings from multidisciplinary evaluation of children with permanent hearing loss. Int J Pediatr Otorhinolaryngol. 2011;75:1040–1044. [level 3]
  • Mafong DD, Shin EJ, Lalwani AK. Use of laboratory evaluation and radiologic imaging in the diagnostic evaluation of children with sensorineural hearing loss. Laryngoscope. 2002;112:1–7. [level 3]
  • Caye-Thomasen P, Dam MS, Omland SH, et al. Cochlear ossification in patients with profound hearing loss following bacterial meningitis. Acta Otolaryngol. 2012;132:720–725. [level 3]
  • Licameli G, Kenna M. Is computerised tomography [CT] or magnetic resonance imaging [MRI] more useful in the evaluation of pediatric sensorineural hearing loss? Laryngoscope. 2010;120:2358–2359. [level 2+]
  • Sennaroglu L, Saatci I, Aralasmak A, et al. Magnetic resonance imaging versus computed tomography in pre-operative evaluation of cochlear implant candidates with congenital hearing loss. J Laryngol Otol. 2002;116:804–810. [level 3]
  • Brown ED, Chau JK, Atashband S, et al. A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J Pediatr Otorhinolaryngol. 2009;73:707–711. [level 2++]
  • de Jong EP, Vossen AC, Walther FJ. How to use… neonatal TORCH testing. Arch Dis Child Educ Pract Ed. 2013;98:93–98.
  • Sánchez PJ, Wendel GD, Norgard MV. Congenital syphilis associated with negative results of maternal serologic tests at delivery. Am J Dis Child. 1991;145:967–969. [Review]
  • Rawstron S, Mehta S, Bromberg K. Evaluation of a Treponema pallidum-specific IgM enzyme immunoassay and Treponema pallidum western blot antibody detection in the diagnosis of maternal and congenital syphilis. Sex Transm Dis. 2004;31:123–126. [level 3]
  • Torre P, Zeldow B, Hoffman HJ, et al. Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents. Pediatr Infect Dis J. 2012;31:835–841. [level 2-]
  • Bogazzi F, Russo D, Raggi F, et al. Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct. J Endocrinol Invest. 2004;27:430–435. [level 2-]
  • Iwasaki S, Tsukamoto K, Usami S, et al. Association of SLC26A4 mutations with clinical features and thyroid function in deaf infants with enlarged vestibular aqueduct. J Hum Genet. 2006;51:805–810. [level 2-]
  • Reddy MV, Satyanarayana VV, Hemabindu L, et al. Immunological studies in children with hearing impairment. J Indian Med Assoc. 2005;103:520–521. [level 3]
  • Agrup C, Luxon LM. Immune-mediated inner-ear disorders in neuro-otology. Curr Opin Neurol. 2006;19:26–32. [Review]
  • Wang RY, Earl DL, Ruder RO, et al. Syndromic ear anomalies and renal ultrasounds. Pediatrics. 2001;108:E32. [level 3]
  • Morales Angulo C, Gallo-Terán J, Señaris B, et al. [Prevalence of the A1555G MTDNA mutation in sporadic hearing-impaired patients without known history of aminoglycoside treatment]. Acta Otorrinolaringol Esp. 2011;62:83–86. [level 3]
  • Raglan E, Radomskij P, Veness J, et al. An audio-vestibular study of 128 children presenting to a specialised paediatric audio-vestibular clinic: should every child with hearing impairment have vestibular function assessed? Audiol Med. 2009;7:143–147. [level 3]
  • Inoue A, Iwasaki S, Ushio M, et al. Effect of vestibular dysfunction on the development of gross motor function in children with profound hearing loss. Audiol Neurootol. 2013;18:143–151. [level 3]
  • De Kegel A, Maes L, Baetens T, et al. The influence of a vestibular dysfunction on the motor development of hearing-impaired children. Laryngoscope. 2012;122:2837–2843. [level 3]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.